Therapeutic Vaccines Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report ID: GMI3239

Summary Methodology

Therapeutic Vaccines Market size is expected to grow significantly from 2019 to 2025.

Rising awareness among the people for severe diseases and growing R&D investments for therapeutic vaccines are the major factors that drive therapeutic vaccines market growth. Prominent players in the industry are focusing on R&D activities for developing innovative products that should further drive business growth over the coming years. For instance, according to Pharma Intelligence data Novartis had 251 number of drugs in pipeline in 2017 and GlaxoSmithKline had 250 number of drugs in pipeline in 2017. Such robust pipeline of prominent players should offer immense growth opportunities during the forecast timeline.

Rising prevalence of HIV, cardiovascular diseases, chronic diseases, infectious diseases as well as cancer accelerates the demand for therapeutic vaccines thus should foster industry growth in foreseeable future. In 2017 according to Avert organization 36.9 million individuals were estimated with HIV that included worldwide HIV prevalence of 0.8% amongst adults and 1.8 million children. Additionally, about 25% of individuals were unaware of the virus they have. Initiatives undertaken by government that provides education and information about AIDS to increase awareness in the community should boost business growth. However, higher cost of vaccines may impede industry growth to some extent. 

Autologous vaccines segment is anticipated to witness robust growth during the forecast period. It is a personalized vaccine obtained from an individual’s own cells by immune system cells or cancer cells. The goal is to treat cancer, or tumor present inside one’s body. Growing prevalence of cancer will drive the demand for autologous vaccines.

Autoimmune disease vaccines segment will account for considerable revenue share owing to rising incidence of autoimmune diseases over the years. According to The American Autoimmune Related Diseases Association (AARDA) autoimmune disease ranks among top ten being the foremost cause of death in female children and women of age group up to 64 years. In addition researchers have identified 80 to 100 various autoimmune diseases that should boost segment growth over the coming years.

Adults segment will witness substantial business growth during the forecast timeframe on account of increasing awareness among adult population regarding chronic diseases. Furthermore, growing incidence of cardiovascular diseases further drives the segment growth. As per American Heart Association from 2013 to 2016 around 121 million American adults had some type of cardiovascular disease. Such high prevalence of cardiovascular disease among adult population will boost segmental growth.

North America therapeutic vaccines industry will account for significant revenue share owing to growing incidence of chronic diseases coupled with rising health concerns among population in the region. Moreover, developed infrastructure with increasing government funding will provide growth opportunities. Development of novel vaccines and technological advancements will boost the regional growth.

Few of the competitors operating in the therapeutic vaccines industry include Agenus, Bavarian Nordic, Celtic Pharma, Cytos Biotechnology, Dendreon, GlaxoSmithKline, Pfizer, Novartis and Merck Serono. Some of the industry players operating in this industry adopt various strategies to have a competitive edge over other players and to sustain in the market for longer run that should boost industry growth.

Therapeutic Vaccines Market By Type, 2015-2025 (USD Million)

  • Allogeneic vaccines
  • Autologous vaccines

Therapeutic Vaccines Market By Application, 2015-2025 (USD Million)

  • Autoimmune disease vaccines
  • Cancer vaccines
  • Infectious disease vaccines
  • Neurological disease vaccines
  • Others

Therapeutic Vaccines Market By End-user, 2015-2025 (USD Million)

  • Adults
  • Pediatrics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa
    • South Africa
    • UAE

Company Profiles:

  • Agenus Inc.
  • Bavarian Nordic
  • Celtic Pharma
  • Cytos Biotechnology
  • Dendreon Corp
  • GlaxoSmithKline
  • Pfizer
  • Merck Serono
  • Novartis

What Information does this report contain?

Historical data coverage: 2016 to 2020; Growth Projections: 2021 to 2027.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Customize this Report

Pre Book Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X